Certified by Founder Lodge
BioLamina
Sweden - Sundbyberg
START UP
1 Disclosed Funding Rounds $18,216,000
0 Participating Investments
-
Founded date
2009
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a va
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 12 ,2023 | Unknown | $18,216,000 |
LAUXERA CAPITAL PARTNERS
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
